Repositioning renal denervation in resistant hypertension: evidence-based insights, stratified decision-making, and implementation pathways
Frontiers in Cardiovascular Medicine · 29.05.2026 · 13
DOI: 10.3389/fcvm.2026.1844520 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 29.05.2026. Verfasst von Min Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijin…. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Renal denervation (RDN) is a catheter-based interventional approach that targets renal sympathetic nerves to modulate sympathetic overactivity, a key pathophysiological driver of resistant hypertension and associated cardiovascular complications. In contrast to pharmacological approaches, the therapeutic effect of RDN does not rely on patient adherence. Originally indicated for severe resistant hypertension, RDN has since shown consistent antihypertensive efficacy across a broad range of hypertensive patients in recent sham-controlled studies. In this review, we discuss the pathophysiological foundation underlying RDN, consolidate the current clinical evidence supporting its therapeutic efficacy, describe the spectrum of available ablation technologies, and evaluate its expanding applications in conditions driven by sympathetic overactivity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Zitieren
APA
Li, M., Yang, D., Cheng, X., Wei, Q., & Zhang, D. (2026). Repositioning renal denervation in resistant hypertension: evidence-based insights, stratified decision-making, and implementation pathways. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1844520
Vancouver
Li M, Yang D, Cheng X, Wei Q, Zhang D. Repositioning renal denervation in resistant hypertension: evidence-based insights, stratified decision-making, and implementation pathways. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1844520
BibTeX
@article{Li2026,
author = {Li, Min and Yang, Ding and Cheng, Xu and Wei, Qiong and Zhang, Dongmei},
title = {Repositioning renal denervation in resistant hypertension: evidence-based insights, stratified decision-making, and implementation pathways},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1844520}
}
EUVIMED